Nephritic factor autoantibodies

Autoantibodies

Volumn , Issue , 2007, Pages 561-566

  Tsokos, George C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053222840     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044452763-9/50073-1     Document Type: Chapter

References (11)

1. Spitzer RE, Vallota EH, Forristal J, Sudora E, Stitzel A, Davis NC, West CD Serum C'3 lytic system in patients with glomerulonephritis. Science 1969, 164:436-437.
2. Peters DK, Charlesworth JA, Sissons JG, Williams DG, Boulton-Jones JM, Evans DJ, Kourilsky O, Morel-Maroger L Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet 1973, 2:535-538.
3. Spitzer RE, Stitzel AE, Tsokos G On the origin of C3 nephritic factor (antibody to the alternative pathway C3 convertase): Evidence for the Adam and Eve concept of autoantibody production. Clin Immunol Immunopathol 1992, 64:177-183.
4. Daha MR, Fearon DT, Austen KF Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF). J Immunol 1976, 116:568-570.
5. Hiramatsu M, Tsokos GC A factor activating complement via the alternative pathway in the supernatants of B cell lines transformed by Epstein-Barr virus and in sera obtained from patients with systemic lupus erythematosus. Int Arch Allergy Appl Immunol 1988, 86:209-214.
6. Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz Hu, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Wurzner R, Zipfel PF Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update. J Am Soc Nephrol 2005, 16:1392-1403.
7. Daha MR, van Es LA Further evidence for the antibody nature of C3 nephritic factor (C3NeF). J Immunol 1979, 123:755-758.
8. Spitzer RE, Stitzel AE, Tsokos GC Autoantibody to the alternative pathway C3/C5 convertase its anti-idiotypic response.A study in affinity. J Immunol 1992, 148:137-141.
9. Spitzer RE, Stitzel AE, Tsokos GC Evidence that production of autoantibody to the alternative pathway C3 convertase is a normal physiologic event. J Pediatr 1990, 116:S103-S108.
10. Daha MR, Austen KF, Fearon DT Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor. J Immunol 1978, 120:1389-1394.
11. Victor KD, Pascual V, Stitzel AE, Tsokos GC, Capra JD, Spitzer RE Nucleotide sequence of a human autoantibody to the alternative pathway C3/C5 convertase (C3NeF). Hybridoma 1993, 12.